![中国首款自研P-CAB替戈拉生片获批 罗欣药业“创仿结合”战略迎新里程碑](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
结语
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
参考资料:
-
https://endpts.com/provention-bio-takes-a-125m-loan-to-advance-eli-lillys-once-rejected-diabetes-drug/
-
各公司官网
-
一定是有一个是错的:同样管线,国内Biotech估值=4个美股公司
-
其他公开资料
封面图来源:123rf
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
推荐阅读
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![融不到就借!知名biotech贷款1.25亿美元续命,力推的一款产品竟是捡来的...](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
本篇文章来源于微信公众号:药时代
发布者:永恒,转载请首先联系contact@drugtimes.cn获得授权